Table 3.
Results of spearman correlation analysis for Treg, Th17 and Treg/Th17 to liver inflammation indicators
| Th17 | Treg | Treg/Th17 | ||||||
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| Group | Mean±SD | r | p-value | r | p-value | r | p-value | |
| HBV | ALT (U/L) | 131.2±167.64 | 0.08 | 0.4630 | 0.02 | 0.8297 | -0.06 | 0.5903 |
| AST (U/L) | 99.58±133.02 | 0.00 | 0.9729 | 0.15 | 0.1501 | 0.08 | 0.4481 | |
| PT (s) | 13.06±2.24 | 0.09 | 0.3622 | 0.23 | 0.0217* | -0.01 | 0.8908 | |
| TB (μmol/L) | 48.02±71.36 | 0.15 | 0.1586 | 0.17 | 0.1018 | -0.08 | 0.4562 | |
| DB (μmol/L) | 23.34±43.26 | 0.11 | 0.2677 | 0.17 | 0.1034 | -0.05 | 0.5955 | |
| WBC (*109/L) | 4.40±1.79 | -0.05 | 0.6246 | -0.27 | 0.0088** | -0.07 | 0.5236 | |
| ALB (g/L) | 37.74±7.3 | 0.02 | 0.8406 | -0.10 | 0.3485 | -0.05 | 0.6347 | |
| HBV-DNA (Log10copies /ml) | 3.74±3.07 | 0.09 | 0.3964 | 0.01 | 0.8903 | -0.06 | 0.5679 | |
| CHB | ALT (U/L) | 230.49±207.5 | 0.23 | 0.1417 | 0.32 | 0.0347* | 0.23 | 0.3998 |
| AST (U/L) | 120.70±119.4 | 0.06 | 0.6907 | 0.32 | 0.0376* | 0.06 | 0.6551 | |
| PT (s) | 12.21±1.9 | 0.25 | 0.1129 | 0.34 | 0.0265* | 0.25 | 0.5627 | |
| TB (μmol/L) | 35.52±33.85 | 0.18 | 0.2549 | 0.32 | 0.0341* | 0.18 | 0.8626 | |
| DB (μmol/L) | 18.48±22.06 | 0.20 | 0.1941 | 0.28 | 0.0730 | -0.10 | 0.5351 | |
| WBC (*109/L) | 4.73±1.21 | -0.02 | 0.8967 | -0.13 | 0.3905 | -0.02 | 0.9551 | |
| ALB (g/L) | 42.23±5.8 | 0.01 | 0.9272 | -0.15 | 0.3296 | 0.01 | 0.5282 | |
| HBV-DNA (Log10 copies/ml) | 5.09±2.78 | -0.03 | 0.8655 | -0.01 | 0.9515 | 0.04 | 0.8065 | |
| HBV-LC | ALT (U/L) | 43.03±35.65 | 0.09 | 0.6352 | -0.08 | 0.6841 | -0.20 | 0.2954 |
| AST (U/L) | 52.24±35.21 | -0.04 | 0.8527 | -0.16 | 0.3989 | -0.10 | 0.5589 | |
| PT (s) | 14.16±2.35 | -0.08 | 0.6690 | -0.13 | 0.5145 | 0.02 | 0.9332 | |
| TB (μmol/L) | 46.15±30.34 | -0.15 | 0.4258 | -0.43 | 0.0194* | -0.02 | 0.9312 | |
| DB (μmol/L) | 22.56±18.68 | -0.17 | 0.3765 | -0.41 | 0.0276* | 0.00 | 0.9899 | |
| WBC (*109/L) | 3.90±1.87 | -0.11 | 0.5531 | -0.43 | 0.0197* | -0.15 | 0.4288 | |
| ALB (g/L) | 33.04±6.9 | 0.03 | 0.8719 | 0.00 | 0.9980 | -0.07 | 0.7364 | |
| HBV-DNA (Log10 copies/ml) | 2.88±2.73 | 0.16 | 0.4497 | 0.28 | 0.1625 | -0.13 | 0.5353 | |
| HBV-HCC | ALT (U/L) | 60.00±48.75 | 0.17 | 0.4407 | 0.13 | 0.5577 | -0.02 | 0.9195 |
| AST (U/L) | 118.9±203.69 | 0.10 | 0.6420 | 0.29 | 0.1633 | 0.12 | 0.5737 | |
| PT (s) | 13.24±2.13 | 0.01 | 0.9742 | 0.17 | 0.4237 | 0.08 | 0.7036 | |
| TB (μmol/L) | 72.67±129.96 | 0.33 | 0.1118 | 0.25 | 0.2481 | -0.28 | 0.1865 | |
| DB (μmol/L) | 32.97±79.22 | 0.13 | 0.5572 | 0.27 | 0.2073 | -0.05 | 0.8338 | |
| WBC (*109/L) | 4.43±2.42 | 0.05 | 0.8150 | -0.17 | 0.4355 | -0.05 | 0.8181 | |
| ALB (g/L) | 35.36±5.44 | 0.15 | 0.4714 | 0.14 | 0.5114 | -0.04 | 0.8670 | |
| HBV-DNA (Log10 copies/ml) | 1.95±2.87 | -0.19 | 0.4113 | -0.05 | 0.8358 | 0.30 | 0.2034 | |
Alanine aminotransferase (ALT), aspartate aminotransferase (AST), prothrombin time (PT), total bilirubin (TBIL), direct bilirubin (DBIL), albumin (ALB), white blood cell (WBC).
*
P<0.005;
**
P<0.001.